HIGHLIGHTS
- who: Schulz and Eduard from the Division of, University of Graz, Austria have published the research: Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms, in the Journal: (JOURNAL) of 31/Dec/2010
- what: The authors performed systematic pedigree and mutational analyses on patients with t-MNs seen at a tertiary cancer centre. The study demonstrates that cancer predisposition syndromes are prevalent in patients with t-MNs and can be identified by conventional pedigree analysis as well as systematic mutational screens.
- how . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.